Immune Response and Pain

Learn more about the relation between immune response and pain and how a better understanding is important for therapeutic implications.

The relationship between the immune response and pain is complex and multifaceted, involving intricate interactions between the nervous and immune systems. Pain, a critical component of the body’s defense mechanism, signals potential or actual damage to tissues, prompting behaviors that protect the body from harm. The immune response, on the other hand, is the body’s defense against pathogens, involving a wide array of cells and molecules designed to identify and eliminate foreign invaders. Both systems work in concert to maintain homeostasis and health, with immune response often influencing pain perception and vice versa.

The Immune System and Pain: An Overview

The immune system comprises innate and adaptive components. The innate immune system provides the first line of defense through physical barriers (like skin and mucous membranes) and immune cells (such as macrophages and neutrophils). When tissue damage or infection occurs, these cells release inflammatory mediators, including cytokines, chemokines, and prostaglandins, which initiate the inflammatory response.

The adaptive immune system involves lymphocytes, including T and B cells, which respond to specific antigens. Upon encountering an antigen, these cells proliferate and differentiate, generating a tailored response to the pathogen. This process also includes the formation of memory cells, which provide long-term immunity.

Pain as a Result of Inflammation

Inflammation is a key component of the immune response and is closely associated with pain. When tissues are damaged or infected, immune cells release pro-inflammatory cytokines such as interleukins (IL-1, IL-6) and tumor necrosis factor-alpha (TNF-α). These cytokines sensitize nociceptors—specialized sensory neurons that detect noxious stimuli. Sensitized nociceptors lower their threshold for activation, making them more responsive to stimuli that would not normally provoke pain. This process, known as peripheral sensitization, results in hyperalgesia (increased sensitivity to pain) and allodynia (pain from stimuli that do not usually cause pain).

Prostaglandins, another group of inflammatory mediators, play a crucial role in pain and inflammation. Cyclooxygenase (COX) enzymes produce prostaglandins, which can directly sensitize nociceptors. Nonsteroidal anti-inflammatory drugs (NSAIDs) like ibuprofen work by inhibiting COX enzymes, thereby reducing prostaglandin production and alleviating pain.

Neuropathic Pain and Immune Response

Neuropathic pain arises from damage to the nervous system itself and is often chronic and difficult to treat. Immune cells contribute to neuropathic pain by interacting with the nervous system at multiple levels. For instance, after nerve injury, resident and infiltrating immune cells release cytokines and chemokines, which contribute to the development and maintenance of neuropathic pain.

Microglia, the resident immune cells of the central nervous system (CNS), become activated in response to nerve injury. Activated microglia release pro-inflammatory mediators that enhance pain signaling pathways within the spinal cord. Similarly, astrocytes, another type of glial cell in the CNS, can become reactive and contribute to the maintenance of chronic pain through the release of inflammatory substances.

The Role of the Adaptive Immune System

The adaptive immune system also influences pain, particularly in chronic conditions. For example, in autoimmune diseases like rheumatoid arthritis and multiple sclerosis, the body’s immune system mistakenly targets its own tissues, leading to inflammation and pain. T cells, particularly Th1 and Th17 subsets, produce cytokines that drive inflammation and contribute to pain. Regulatory T cells (Tregs), which normally suppress immune responses and maintain tolerance, are often dysfunctional in these conditions, allowing unchecked inflammation and pain.

Autoantibodies, produced by B cells, can directly contribute to pain by binding to neuronal antigens and altering nerve function. In diseases like Guillain-Barré syndrome, antibodies against peripheral nerve components can lead to severe neuropathic pain.

Pain Modulation by Immune Cells

While immune responses often exacerbate pain, certain immune cells and mediators can also suppress pain. For instance, anti-inflammatory cytokines such as IL-10 and transforming growth factor-beta (TGF-β) can inhibit the activity of pro-inflammatory cytokines and reduce pain. Tregs and certain types of macrophages produce these anti-inflammatory mediators, highlighting a regulatory mechanism that can counteract pain.

Moreover, the resolution phase of inflammation involves the clearance of pro-inflammatory cells and mediators and the promotion of tissue repair. Specialized pro-resolving mediators (SPMs) such as resolvins, protectins, and maresins are derived from omega-3 fatty acids and play a crucial role in resolving inflammation and reducing pain.

The Brain-Immune Connection

The interplay between the immune system and pain is not limited to peripheral tissues but also involves the central nervous system. The brain can modulate immune function via the hypothalamic-pituitary-adrenal (HPA) axis and autonomic nervous system. Stress and pain perception can influence immune responses, and conversely, immune signals can affect brain function and pain perception.

Cytokines released during systemic inflammation can cross the blood-brain barrier or signal through the vagus nerve, affecting brain regions involved in pain processing. This interaction underscores the bidirectional communication between the immune and nervous systems, which is crucial for understanding conditions like fibromyalgia and chronic fatigue syndrome, where pain and immune dysregulation are prominent features.

Therapeutic Implications

Understanding the relationship between the immune response and pain has significant therapeutic implications. Targeting immune pathways offers potential strategies for pain management. For example, biological therapies such as TNF inhibitors (used in rheumatoid arthritis) can reduce inflammation and alleviate pain. Similarly, monoclonal antibodies against nerve growth factor (NGF) are being explored for chronic pain conditions.

Emerging therapies aim to harness the body’s natural mechanisms for resolving inflammation. SPMs and their analogs represent a promising avenue for developing new pain treatments that promote resolution rather than merely suppressing inflammation.


The relationship between the immune response and pain is a dynamic interplay that involves complex signaling networks between the nervous and immune systems. Inflammation, a key component of the immune response, is a major driver of pain, particularly in chronic conditions. Both pro-inflammatory and anti-inflammatory mediators influence pain perception, highlighting the dual role of the immune system in modulating pain. Understanding these interactions opens new avenues for therapeutic interventions, offering hope for more effective and targeted pain management strategies.

Immune Modelling & Experimental Design

Immune Risk Assessment

Tissue Damage & Cytotoxicity

Immuno-Oncology & Immunotoxicity

Inflammation & Systemic Diseases

Vaccines, Drug Delivery & Transfection

Signalling Pathways

Looking for a tailored solution?

Of course, there is no one-size-fits-all solution for most studies. Immundnz specializes in developing tailored assays to enable you to challenge the status quo in your research.


Some of our popular assays

To accelerate your research and deliver high-quality data, Immundnz offers a broad spectrum of standardized, proven assays that are readily available.

M1/M2 Polarisation

M1/M2 are important in studies of various therapeutic areas and biological pathways.



Phagocytosis is an immunologic mechanism involved in apoptosis, necrosis, infection and tumour conditions mediated by leukocytes like macrophages, DCs, and neutrophils. 

Cytokine Release Assay

Cytokine release assay (CRA) is vital in biopharmaceutical discovery and development and life science research.


Dendritic Cell Maturation

Dendritic cells (DCs) are the star antigen-presenting cells (APCs) of myeloid or haematopoietic origin that play a vital role between the innate and adaptive immune systems. 


T Cell Differentiation

The T cell proliferation assay can be used to assess modulation of the T cell response by (immunomodulatory) compounds.


Immune & Protein-Based

We perform various immunologic and protein-based assays that are needed in your research or drug development.


Case Studies

Immundnz has performed many case studies, some of which are described here. You can always reach out to us for other examples of projects we have done.


Immundnz shares insights on in vitro immunology research for drug discovery on its blog, which is regularly updated by experts in the field.